- Home
- BMRN vs JNPR Comparison
BMRN vs JNPR Comparison
Compare BMRN & JNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- JNPR
- Stock Information
- Founded
- BMRN 1996
- JNPR 1996
- Country
- BMRN United States
- JNPR United States
- Employees
- BMRN N/A
- JNPR N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- JNPR Computer Communications Equipment
- Sector
- BMRN Health Care
- JNPR Telecommunications
- Exchange
- BMRN Nasdaq
- JNPR Nasdaq
- Market Cap
- BMRN 12.1B
- JNPR 12.1B
- IPO Year
- BMRN 1999
- JNPR 1999
- Fundamental
- Price
- BMRN $55.00
- JNPR $36.04
- Analyst Decision
- BMRN Buy
- JNPR Buy
- Analyst Count
- BMRN 22
- JNPR 6
- Target Price
- BMRN $93.43
- JNPR $40.00
- AVG Volume (30 Days)
- BMRN 2.2M
- JNPR 2.0M
- Earning Date
- BMRN 08-04-2025
- JNPR 07-24-2025
- Dividend Yield
- BMRN N/A
- JNPR 2.45%
- EPS Growth
- BMRN 152.82
- JNPR 51.37
- EPS
- BMRN 2.71
- JNPR 1.04
- Revenue
- BMRN $2,950,227,000.00
- JNPR $5,204,900,000.00
- Revenue This Year
- BMRN $12.23
- JNPR $9.35
- Revenue Next Year
- BMRN $9.99
- JNPR $3.91
- P/E Ratio
- BMRN $20.29
- JNPR $34.40
- Revenue Growth
- BMRN 19.36
- JNPR N/A
- 52 Week Low
- BMRN $52.93
- JNPR $33.42
- 52 Week High
- BMRN $94.85
- JNPR $39.79
- Technical
- Relative Strength Index (RSI)
- BMRN 35.12
- JNPR 53.71
- Support Level
- BMRN $54.46
- JNPR $35.70
- Resistance Level
- BMRN $58.17
- JNPR $36.09
- Average True Range (ATR)
- BMRN 1.39
- JNPR 0.25
- MACD
- BMRN -0.04
- JNPR 0.00
- Stochastic Oscillator
- BMRN 13.08
- JNPR 87.80
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About JNPR Juniper Networks Inc.
Juniper Networks Inc is engaged in designing, developing, and selling products and services for high-performance networks to enable customers to build scalable, reliable, secure, and cost-effective networks for their businesses while achieving agility and improved operating efficiency through automation. The company's high-performance network and service offerings include routing, switching, Wi-Fi, network security, artificial intelligence (AI) or AI-enabled enterprise networking operations (AIOps), and software-defined networking (SDN) technologies. In addition to the company's products, the company offers its customers a variety of services, including maintenance and support, professional services, Software-as-a-Service (SaaS), and education and training programs.